345
Participants
Start Date
November 16, 2016
Primary Completion Date
March 16, 2018
Study Completion Date
March 16, 2018
bempedoic acid
bempedoic acid 180 mg tablet
placebo
Matching placebo tablet
Gilbert
Anaheim
Long Beach
Sacramento
Santa Ana
Torrance
Ventura
Hamden
Daytona Beach
Fort Lauderdale
Site 1, Miami
Site 2, Miami
Orlando
West Palm Beach
Atlanta
Savannah
Meridian
Evanston
Evansville
Iowa City
Waterloo
Monroe
Slidell
Tupelo
Lincoln
Somerset
Binghamton
Endwell
New Windsor
Greensboro
Morganton
Mount Airy
Columbus
Marion
Maumee
Oklahoma City
Beaver
Langhorne
Cumberland
Anderson
Summerville
Jackson
Knoxville
Memphis
Amarillo
Site 1, Dallas
Site 2, Dallas
Houston
San Antonio
Clinton
Hampton
Kenosha
Brossard
Chicoutimi
Gatineau
London
Longueuil
Mirabel
Montreal
Newmarket
Oakville
Peterborough
Pointe-Claire
Saint-Jérôme
Sarnia
Toronto
Victoriaville
Lead Sponsor
Esperion Therapeutics, Inc.
INDUSTRY